Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study (ASSET-3)

This study has been terminated.
(Slow enrollment)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:
Actelion Identifier:
First received: August 2, 2006
Last updated: February 11, 2010
Last verified: February 2010
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):